Partner Dan Shores will speak on "Navigating the IP Landscape in the mRNA Space" at the 2nd Annual mRNA-Based Therapeutics Summit being held July 26-28, 2022, in Boston, Massachusetts.
Dan's session, taking place during the Pre-Conference Focus Day on Tuesday, July 26, will cover the current IP and competitive landscape for mRNA and LNP delivery technology; strategies for freedom to operate, design-around, and licensing; and IP protection strategies for new innovations.
The mRNA industry has welcomed significant advancements in the next generation of mRNA vaccines and therapeutics with applications in indications beyond COVID-19 since the start of the pandemic. Now, the landscape for successful treatments seems limitless, and the future is brighter than ever for mRNA therapies. The mRNA-Based Therapeutics Summit is the world's only end-to-end meeting focused on the development of mRNA vaccines and therapies from early basic research through commercialization and to the patients in need.
To learn more about the event, please click here.
